Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AFLIBERCEPT vs BEVACIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AFLIBERCEPT vs BEVACIZUMAB: Safety Overview

Metric AFLIBERCEPT BEVACIZUMAB
Total FAERS Reports 26,891 78,112
Deaths Reported 8,527 17,498
Death Rate 31.7% 22.4%
Hospitalizations 3,193 23,114
Average Patient Age 70.5 yrs 61.1 yrs
% Female Patients 50.9% 55.0%
Manufacturer Regeneron Pharmaceuticals, Inc. Biocon Biologics Inc.
Route INTRAVITREAL INTRAVASCULAR
Marketing Status Prescription Prescription